Related Experiment Video

Updated: Jun 20, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

22.7K

Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response

Rhea Nickerson1, Christina S Thornton2,3, Brent Johnston1

  • 1Department of Microbiology and Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada.

Frontiers in Immunology
|July 17, 2024
PubMed

Insights

Chronic Pseudomonas aeruginosa lung infections involve ineffective immune responses that damage the lungs. Understanding this interplay is key to developing new treatments for persistent bacterial infections.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen causing chronic lung infections, notably in cystic fibrosis.
  • Host immune responses often fail to clear persistent infections, leading to inflammation and lung damage.

Purpose of the Study:

  • To review the host immune response to chronic Pseudomonas aeruginosa lung infections.
  • To explore how immune responses contribute to lung damage and bacterial persistence.
  • To identify strategies for modulating immune responses to improve treatment outcomes.

Main Methods:

  • This is a review article, synthesizing existing research.
  • It examines pathogen recognition, innate immunity, and adaptive immunity.
  • The focus is on the immune response within the lung environment.

Main Results:

  • Initial pathogen recognition triggers a strong innate immune response.
  • This innate response is often maladaptive, contributing to inflammation.
  • The adaptive immune response is ineffective, allowing bacterial persistence and ongoing lung damage.

Conclusions:

  • The immune response to chronic Pseudomonas aeruginosa lung infections is a double-edged sword, causing damage while failing to clear the pathogen.
  • Further research into the host-pathogen-immune system interaction is needed.
  • Targeting immune modulation alongside antimicrobial strategies may offer new therapeutic avenues.
Keywords:
Pseudomonas aeruginosaadaptive immune responsechronic lung diseaseinflammationinnate immune responseneutrophils

More Related Videos

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

8.8K
A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection06:56

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Published on: February 20, 2020

8.5K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
217
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
242
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K